Cloning of a human homolog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2

Genomics
H ChenS E Antonarakis

Abstract

To identify genes that map on human chromosome 21 (HC21) and that may contribute to the phenotype of Down syndrome (DS), exon trapping was applied to cosmid DNA from an HC21-specific library LL21NCO2-Q. More than 550 potential exons were cloned and partially characterized. One of these, hmc23b04 (GenBank X88270) showed strong homology to the Drosophila Enhancer of zeste protein (GenBank U00180) from amino acid 665 to 694 (p = 7.6 x 10(-11). We have cloned the full-length cDNA for this human homolog of the Drosophila E(z) gene (termed EZH2) and mapped it to within YACs 64f11 and 809b11 between markers D21S65 and ERG on human chromosome 21q22.2. Sequence analysis indicates that EZH2 encodes a 746-amino-acid polypeptide that shows 60.5% identity to the Drosophila E(z) protein and contains a trithorax-like domain and a DNA-binding motif. Northern blot analysis revealed that EZH2 is expressed in several tissues. Alternatively spliced mRNA species have been observed. The Drosophila E(z) protein is a member of the polycomb group genes that maintain homeotic gene repression and are thought to control gene expression by regulating chromatin. The strong sequence conservation suggests a possible function of EZH2 in regulation of gene tran...Continue Reading

Citations

May 17, 2006·Oral Diseases·F CarinciF Pezzetti
Dec 1, 2017·Antioxidants & Redox Signaling·María A Pajares, Dolores Pérez-Sala
Sep 24, 2009·British Journal of Cancer·Ø FlugeUNKNOWN Norwegian Gastrointestinal Cancer Group
Feb 11, 2005·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Hugh W Brock, Cynthia L Fisher
Sep 19, 1998·Molecular and Cellular Biology·O DenisenkoK Bomsztyk
Apr 15, 2017·Oncotarget·Xiaobing LiuLongkun Li
Jun 19, 2009·Molecular Reproduction and Development·Ki-Eun ParkRyan A Cabot
Sep 26, 2001·The Journal of Biological Chemistry·S O'ConnellR S Jones
Jan 10, 2012·Molecular Carcinogenesis·Yuan ZhouXue-Jun Zhang
Jun 28, 2012·International Journal of Oncology·Shimpei NishikawaMasaki Mori
Oct 12, 2020·Journal of Leukocyte Biology·Fang-Fei ShaoGuo-Qing Wu
Oct 18, 2020·International Journal of Molecular Sciences·Paul PeixotoEric Hervouet
Dec 15, 2020·Cell & Bioscience·Zhongwei LiJin Bai
Sep 29, 1999·Biochimica Et Biophysica Acta·D P Satijn, A P Otte
Jan 18, 2005·Biochemical and Biophysical Research Communications·Norihisa ShindoToru Higashinakagawa
Nov 27, 2015·New Biotechnology·Melissa BatonickMargaret M Kiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.